Transferrin receptor-mediated transport at the blood-brain barrier is elevated in early development but maintained across adult aging
Torres, V. O.; Pizzo, M. E.; Chan, D.; Dugas, J. C.; Huynh, D.; Joy, D.; Liang, E. K.; Sarrafha, L.; Becerra, I.; Chau, R.; Chew, K. S.; Chow, J.; Earr, T. K.; Khoury, N.; Lechtenberg, K. J.; Leung, A. W.; Nguyen, H. N.; Ojo, E. S.; Roche, E.; Solanoy, H.; Tong, M.; Tong, R. K.; Henne, K.; Lewcock, J. W.; Watts, R. J.; Calvert, M. E.; Thorne, R. G.; Zuchero, J.
Show abstract
Transferrin receptor (TfR)-mediated transcytosis across the blood-brain barrier (BBB) is a promising strategy to improve delivery of biologics to the central nervous system (CNS). However, it remains unclear whether age and aging-related diseases impact TfR expression and/or BBB transport capacity. Here, we used the TfR-targeted antibody transport vehicle (ATVTfR) to enhance CNS delivery in healthy mice and in the 5xFAD mouse model of Alzheimers disease (AD). Healthy neonates exhibited the highest vascular TfR expression and ATVTfR brain exposure, whereas BBB transport capacity remained stable across adulthood. Additionally, neither TfR expression nor ATVTfR brain uptake changed significantly in 5xFAD mice. Further, vascular TfR expression in AD patient brains was similar to age-matched controls, suggesting that TfR transport may be conserved for AD in humans. The elevated TfR-mediated brain delivery observed in early mouse development suggests the potential of added efficacy in utilizing TfR platforms for the treatment of early childhood diseases. Preservation of ATVTfR transport in adult mice across healthy aging and in an AD model supports continued application of TfR platforms in age-related diseases.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology 94%
- A Trem2*R47H mouse model without cryptic splicing drives age- and disease-dependent tissue damage and synaptic loss in response to plaques 93%
- β-Amyloid Induces Microglial Expression of GPC4 and APOE Leading to Increased Neuronal Tau Pathology and Toxicity 93%
Similar papers in this journal
- ACSS2 upregulation enhances neuronal resilience to aging and tau-associated neurodegeneration 95%
- PTP1B inhibition promotes microglial phagocytosis in Alzheimer's disease models by enhancing SYK signaling 94%
- Comprehensive preclinical evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of C9ORF72 disease 93%
Similar papers in this journal
- Age-associated gut microbiota impairs hippocampus-dependent memory in a vagus-dependent manner 92%
- Benefits of global mutant huntingtin lowering diminish over time in a Huntington's disease mouse model 92%
- Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors 92%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.